Galectin Therapeutics, Inc. Skyrocketed
Mon, Apr 19, 2021 at 05:33 PM
Galectin Therapeutics, Inc. (GALT:NASDAQ) rocketted at $2.78, a gain of 26.9%. On Fri, Apr 16, 2021, GALT:NASDAQ hit a New 2-Week Intraday Low of $2.06. The stock appeared on our News Catalysts scanner on Tue, Apr 13, 2021 at 08:09 PM in the 'MERGER' category. From Mon, Apr 05, 2021, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Tue, Apr 06, 2021 at $3.27 with a volume of 18M+.
About Galectin Therapeutics, Inc. (GALT:NASDAQ)
Galectin Therapeutics Inc is a clinical stage biopharmaceutical company. The Company is engaged in drug research and development to create new therapies for fibrotic disease and cancer.
Top 10 Gainers:
- Marlin Business Services Corp. (MRLN:NASDAQ), 50.7%
- Knoll, Inc. (KNL:NYSE), 35.23%
- Ambow Education Holding Ltd. (AMBO:NYSEMKT), 33.15%
- China Green Agriculture, Inc. (CGA:NYSE), 28.29%
- TDH Holdings, Inc. (PETZ:NASDAQ), 27.83%
- Galectin Therapeutics, Inc. (GALT:NASDAQ), 26.94%
- CMMB (CMMB:NASDAQ), 26.52%
- BBQ Holdings, Inc. (BBQ:NASDAQ), 23.26%
- American River Bankshares (AMRB:NASDAQ), 23.22%
- Moxian, Inc. (MOXC:NASDAQ), 21.73%